Homocysteine and inflammation as main determinants of oxidative stress in the elderly

Free Radical Biology and Medicine

Volumn 46, Issue 6, 2009, Pages 737-744

  Ventura, Emilie ^a,b   Durant, Richard ^c   Jaussent, Audrey ^d   Picot, Marie Christine ^d   Morena, Marion ^b   Badiou, Stéphanie ^a,b   Dupuy, Anne Marie ^a   Jeandel, Claude ^c   Cristol, Jean Paul ^a,b  

^a LAPEYRONIE HOSPITAL   (France)

^b UNIV MONTPELLIER   (France)

^c CHU   (France)

^d HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Aging; Free radicals; Hyperhomocysteinemia; Inflammation; Superoxide anion

Indexed keywords

ALBUMIN; BETA ACTIN; C REACTIVE PROTEIN; CHOLESTEROL; CYANOCOBALAMIN; FIBRINOGEN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; HOMOCYSTEINE THIOLACTONE; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUCIGENIN; OROSOMUCOID; PREALBUMIN; PROTEIN P22; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE; TRIACYLGLYCEROL;

AGED; AGING; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; INFLAMMATION; MALE; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AGED; AGED, 80 AND OVER; AGING; C-REACTIVE PROTEIN; CELL LINE; ENZYME ACTIVATION; FEMALE; HOMOCYSTEINE; HUMANS; INFLAMMATION; LIPID METABOLISM; MALE; MONOCYTES; NADPH OXIDASE; NUTRITION ASSESSMENT; OXIDATIVE STRESS; PREALBUMIN; SUPEROXIDES;

EID: 60749129445     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2008.11.002     Document Type: Article

References (64)

1. Refsum H., Smith A.D., Ueland P.M., Nexo E., Clarke R., McPartlin J., Johnston C., Engbaek F., Schneede J., McPartlin C., and Scott J.M. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin. Chem. 50 (2004) 3-32
2. Clarke R., Grimley Evans J., Schneede J., Nexo E., Bates C., Fletcher A., Prentice A., Johnston C., Ueland P.M., Refsum H., Sherliker P., Birks J., Whitlock G., Breeze E., and Scott J.M. Vitamin B12 and folate deficiency in later life. Age Ageing 33 (2004) 34-41
3. Refsum H., Ueland P.M., Nygard O., and Vollset S.E. Homocysteine and cardiovascular disease. Annu. Rev. Med. 49 (1998) 31-62
4. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br. Med. J. 325 (2002) 1202
5. Herrmann M., Taban-Shomal O., Hubner U., Bohm M., and Herrmann W. A review of homocysteine and heart failure. Eur. J. Heart Fail. 8 (2006) 571-576
6. Welch G.N., and Loscalzo J. Homocysteine and atherothrombosis. N. Engl. J. Med. 338 (1998) 1042-1050
7. Tsai J.C., Perrella M.A., Yoshizumi M., Hsieh C.M., Haber E., Schlegel R., and Lee M.E. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc. Natl. Acad. Sci. USA 91 (1994) 6369-6373
8. Hofmann M.A., Lalla E., Lu Y., Gleason M.R., Wolf B.M., Tanji N., Ferran Jr. L.J., Kohl B., Rao V., Kisiel W., Stern D.M., and Schmidt A.M. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J. Clin. Invest. 107 (2001) 675-683
9. Desai A., Lankford H.A., and Warren J.S. Homocysteine augments cytokine-induced chemokine expression in human vascular smooth muscle cells: implications for atherogenesis. Inflammation 25 (2001) 179-186
10. Durga J., van Tits L.J., Schouten E.G., Kok F.J., and Verhoef P. Effect of lowering of homocysteine levels on inflammatory markers: a randomized controlled trial. Arch. Intern. Med. 165 (2005) 1388-1394
11. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107 (2003) 391-397
12. Krabbe K.S., Pedersen M., and Bruunsgaard H. Inflammatory mediators in the elderly. Exp. Gerontol. 39 (2004) 687-699
13. Cesari M., Penninx B.W., Newman A.B., Kritchevsky S.B., Nicklas B.J., Sutton-Tyrrell K., Tracy R.P., Rubin S.M., Harris T.B., and Pahor M. Inflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study). Am. J. Cardiol. 92 (2003) 522-528
14. Ravaglia G., Forti P., Maioli F., Servadei L., Martelli M., Arnone G., Talerico T., Zoli M., and Mariani E. Plasma homocysteine and inflammation in elderly patients with cardiovascular disease and dementia. Exp. Gerontol. 39 (2004) 443-450
15. Gori A.M., Corsi A.M., Fedi S., Gazzini A., Sofi F., Bartali B., Bandinelli S., Gensini G.F., Abbate R., and Ferrucci L. A proinflammatory state is associated with hyperhomocysteinemia in the elderly. Am. J. Clin. Nutr. 82 (2005) 335-341
16. Khatri J.J., Johnson C., Magid R., Lessner S.M., Laude K.M., Dikalov S.I., Harrison D.G., Sung H.J., Rong Y., and Galis Z.S. Vascular oxidant stress enhances progression and angiogenesis of experimental atheroma. Circulation 109 (2004) 520-525
17. Olsewski A., and Mc Cully K.S. Homocysteine metabolism and the oxidative modification of proteins and lipids. Free Radic. Biol. Med. 14 (1993) 683-693
18. Ventura P., Panini R., Verlato C., Scarpetta G., and Salvidi G. Hyperhomocysteinemia and related factors in 600 hospitalized elderly subjects. Metabolism 50 (2001) 1466-1471
19. Loscalzo J. The oxidant stress of hyperhomocysteinemia. J. Clin. Invest. 98 (1996) 5-7
20. Starkebaum G., and Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J. Clin. Invest. 77 (1986) 1370-1376
21. McCully K.S. Chemical pathology of homocysteine. I. Atherogenesis. Ann. Clin. Lab. Sci. 23 (1993) 477-493
22. Biesalski H.K. Free radical theory of aging. Curr. Opin. Clin. Nutr. Metab. Care 5 (2002) 5-10
23. Babior B.M. The leukocyte NADPH oxidase. Isr. Med. Assoc. J. 4 (2002) 1023-1024
24. Sorescu D., Weiss D., Lassegue B., Clempus R.E., Szocs K., Sorescu G.P., Valppu L., Quinn M.T., Lambeth J.D., Vega J.D., Taylor W.R., and Griendling K.K. Superoxide production and expression of Nox family proteins in human atherosclerosis. Circulation 105 (2002) 1429-1435
25. Ungvari Z., Csiszar A., Edwards J.G., Kaminski P.M., Wolin M.S., Kaley G., and Koller A. Increased superoxide production in coronary arteries in hyperhomocysteinemia: role of tumor necrosis factor-alpha, NAD(P)H oxidase, and inducible nitric oxide synthase. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 418-424
26. Edirimanne V.E., Woo C.W., Siow Y.L., Pierce G.N., Xie J.Y., and O K. Homocysteine stimulates NADPH oxidase-mediated superoxide production leading to endothelial dysfunction in rats. Can. J. Physiol. Pharmacol. 85 (2007) 1236-1247
27. DeLeo F.R., Renee J., McCormick S., Nakamura M., Apicella M., Weiss J.P., and Nauseef W.M. Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly. J. Clin. Invest. 101 (1998) 455-463
28. Dudman N.P., Temple S.E., Guo X.W., Fu W., and Perry M.A. Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats in vivo. Circ. Res. 84 (1999) 409-416
29. Koga T., Claycombe K., and Meydani M. Homocysteine increases monocyte and T-cell adhesion to human aortic endothelial cells. Atherosclerosis 161 (2002) 365-374
30. Papatheodorou L., and Weiss N. Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid. Redox Signaling 9 (2007) 1941-1958
31. Segal A.W., and Abo A. The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem. Sci. 18 (1993) 43-47
32. Descamps-Latscha B., Goldfarb B., Nguyen A.T., Landais P., London G., Haeffner-Cavaillon N., Jacquot C., Herbelin A., and Kazatchkine M. Establishing the relationship between complement activation and stimulation of phagocyte oxidative metabolism in hemodialyzed patients: a randomized prospective study. Nephron 59 (1991) 279-285
33. Fearon D.T., and Collins L.A. Increased expression of C3b receptors on polymorphonuclear leukocytes induced by chemotactic factors and by purification procedures. J. Immunol. 130 (1983) 370-375
34. Durant R., Klouche K., Delbosc S., Morena M., Amigues L., Beraud J.J., Canaud B., and Cristol J.P. Superoxide anion overproduction in sepsis: effects of vitamin E and simvastatin. Shock 22 (2004) 34-39
35. Vachier I., Chanez P., Le Doucen C., Damon M., Descomps B., and Godard P. Enhancement of reactive oxygen species formation in stable and unstable asthmatic patients. Eur. Respir. J. 7 (1994) 1585-1592
36. Delbosc S., Morena M., Djouad F., Ledoucen C., Descomps B., and Cristol J.P. Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, are able to reduce superoxide anion production by NADPH oxidase in THP-1-derived monocytes. J. Cardiovasc. Pharmacol. 40 (2002) 611-617
37. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
38. Koenig W., Sund M., Frohlich M., Fischer H.G., Lowel H., Doring A., Hutchinson W.L., and Pepys M.B. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg cohort study, 1984 to 1992. Circulation 99 (1999) 237-242
39. Mendall M.A., Patel P., Ballam L., Strachan D., and Northfield T.C. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. Br. Med. J. 312 (1996) 1061-1065
40. Cascieri M.A. The potential for novel anti-inflammatory therapies for coronary artery disease. Nat. Rev. Drug Discovery 1 (2002) 122-130
41. Chan S.S., Monteiro H.P., Deucher G.P., Abud R.L., Abuchalla D., and Junqueira V.B. Functional activity of blood polymorphonuclear leukocytes as an oxidative stress biomarker in human subjects. Free Radic. Biol. Med. 24 (1998) 1411-1418
42. Braga P.C., Sala M.T., Dal Sasso M., Mancini L., Sandrini M.C., and Annoni G. Influence of age on oxidative bursts (chemiluminescence) of polymorphonuclear neutrophil leukocytes. Gerontology 44 (1998) 192-197
43. Baynes J.W. The role of AGEs in aging: causation or correlation. Exp. Gerontol. 36 (2001) 1527-1537
44. Poubelle P., Chaintreuil J., Bensadoun J., Blotman F., Simon L., and Crastes de Paulet A. Plasma lipoperoxides and aging: critical assessment of the thiobarbituric acid method for the measurement of lipoperoxides and malondialdehyde. Biomed. Pharmacother. 36 (1982) 164-166
45. Artur Y., Herbeth B., Guemouri L., Lecomte E., Jeandel C., and Siest G. Age-related variations of enzymatic defenses against free radicals and peroxides. EXS 62 (1992) 359-367
46. Andriollo-Sanchez M., Hininger-Favier I., Meunier N., Venneria E., O'Connor J.M., Maiani G., Coudray C., and Roussel A.M. Age-related oxidative stress and antioxidant parameters in middle-aged and older European subjects: the ZENITH study. Eur. J. Clin. Nutr. 59 Suppl. 2 (2005) S58-S62
47. Selhub J., Jacques P.F., Wilson P.W.F., Rush D., and Rosenberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in elderly population. JAMA 270 (1995) 2693-2698
48. Herrmann W., Quast S., Ullrich M., Schultze H., Bodis M., and Geisel J. Hyperhomocysteinemia in high-aged subjects: relation of B-vitamins, folic acid, renal function and the methylenetetrahydrofolate reductase mutation. Atherosclerosis 144 (1999) 91-100
49. Weiss N., Heydrick S., Zhang Y.Y., Bierl C., Cap A., and Lascalzo J. Cellular redox state and endothelial dysfunction in mildly hyperhomocysteinemic cystathionine beta-synthase-deficient mice. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 34-41
50. Kanani P.M., Sinkey C.A., Browning R.L., Allaman M., Knapp H.R., and Haynes W.G. Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocysteinemia in humans. Circulation 100 (1999) 1161-1168
51. Wang G., and O K. Homocysteine stimulates the expression of monocyte chemoattractant protein-1 receptor (CCR2) in human monocytes: possible involvement of oxygen free radicals. Biochem. J. 357 Pt 1 (2001) 233-240
52. Alvarez-Maqueda M., El Bekay R., Monteseirin J., Alba G., Chacon P., Vega A., Santa Maria C., Tejedo J.R., Martin-Nieto J., Bedoya F.J., Pintado E., and Sobrino F. Homocysteine enhances superoxide anion release and NADPH oxidase assembly by human neutrophils: effects on MAPK activation and neutrophil migration. Atherosclerosis 172 (2004) 229-238
53. Siow Y.L., Au-Yeung K.K., Woo C.W., and O K. Homocysteine stimulates phosphorylation of NADPH oxidase p47phox and p67phox subunits in monocytes via protein kinase Cbeta activation. Biochem. J. 398 (2006) 73-82
54. Becker J.S., Adler A., Schneeberger A., Huang H., Wang Z., Walsh E., Koller A., and Hintze T.H. Hyperhomocysteinemia, a cardiac metabolic disease: role of nitric oxide and the p22phox subunit of NADPH oxidase. Circulation 111 (2005) 2112-2118
55. Dupuy A.M., Jaussent I., Lacroux A., Durant R., Cristol J.P., and Delcourt C. Waist circumference adds to the variance in plasma C-reactive protein levels in elderly patients with metabolic syndrome. Gerontology 53 (2007) 91-101
56. Strandberg T.E., and Tilvis R.S. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler. Thromb. Vasc. Biol. 20 (2000) 1057-1060
57. Dalal S., Parkin S.M., Homer-Vanniasinkam S., and Nicolaou A. Effect of homocysteine on cytokine production by human endothelial cells and monocytes. Ann. Clin. Biochem. 40 (2003) 534-541
58. Friso S., Jacques P.F., Wilson P.W., Rosenberg I.H., and Selhub J. Low circulating vitamin B(6) is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine concentrations. Circulation 103 (2001) 2788-2791
59. Rhode L.E., Hennekens C.H., and Ridker P.M. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am. J. Cardiol. 84 (1999) 1018-1022
60. Folsom A.R., Desvarieux M., Nieto F.J., Boland L.L., Ballantyne C.M., and Chabless L.E. B vitamins status and inflammatory markers. Atherosclerosis 169 (2003) 169-174
61. Pasceri V., Willerson J.T., and Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102 (2000) 2165-2168
62. Kobayashi S., Inoue N., Ohashi Y., Terashima M., Matsui K., Mori T., Fujita H., Awano K., Kobayashi K., Azumi H., Ejiri J., Hirata K., Kawashima S., Hayashi Y., Yokozaki H., Itoh H., and Yokoyama M. Interaction of oxidative stress and inflammatory response in coronary plaque instability: important role of C-reactive protein. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1398-1404
63. Pinkus R., Weiner L.M., and Daniel V. Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression. J. Biol. Chem. 271 (1996) 13422-13429
64. Maggi-Capeyron M.F., Ceballos P., Cristol J.P., Delbosc S., Le Doucen C., Pons M., Leger C.L., and Descomps B. Wine phenolic antioxidants inhibit AP-1 transcriptional activity. J. Agric. Food Chem. 49 (2001) 5646-5652